Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2015 | 1 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
kieran lv
Your search for
Jieran Lv
retrieved no results
Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome.
JAMA Cardiol. 2018 Apr 1;3(4):326-334. doi: 10.1001/jamacardio.2017.5235.
JAMA Cardiol. 2018.
PMID: 29466530
Free PMC article.
Other echocardiographic findings, including LV hypertrophy, LV systolic dysfunction, and valve disease, were less prevalent in the first decade and were seen more frequently in the second decade. ...Echocardiographic indicators of LV diastolic function may be …
Other echocardiographic findings, including LV hypertrophy, LV systolic dysfunction, and valve disease, were less prevalent in …
The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats.
Borgeat K, Stern J, Meurs KM, Fuentes VL, Connolly DJ.
Borgeat K, et al.
J Vet Cardiol. 2015 Dec;17 Suppl 1:S258-67. doi: 10.1016/j.jvc.2015.06.005.
J Vet Cardiol. 2015.
PMID: 26776584
CONCLUSIONS: This study provides evidence that the MYBPC3:R820W mutation is independently associated with LV wall thickness in Ragdoll cats. Body weight is also independently associated with maximum LV wall thickness, but is not currently accounted for in HCM screen …
CONCLUSIONS: This study provides evidence that the MYBPC3:R820W mutation is independently associated with LV wall thickness in Ragdol …
Item in Clipboard
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M, Kalluri R.
Eikesdal HP, et al.
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15040-5. doi: 10.1073/pnas.0807055105. Epub 2008 Sep 25.
Proc Natl Acad Sci U S A. 2008.
PMID: 18818312
Free PMC article.
Item in Clipboard
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Pearson ADJ, Rossig C, Lesa G, Diede SJ, Weiner S, Anderson J, Gray J, Geoerger B, Minard-Colin V, Marshall LV, Smith M, Sondel P, Bajars M, Baldazzi C, Barry E, Blackman S, Blanc P, Capdeville R, Caron H, Cole PD, Jiménez JC, Demolis P, Donoghue M, Elgadi M, Gajewski T, Galluzzo S, Ilaria R Jr, Jenkner A, Karres D, Kieran M, Ligas F, Lowy I, Meyers M, Oprea C, Peddareddigari VGR, Sterba J, Stockman PK, Suenaert P, Tabori U, van Tilburg C, Yancey T, Weigel B, Norga K, Reaman G, Vassal G.
Pearson ADJ, et al.
Eur J Cancer. 2020 Mar;127:52-66. doi: 10.1016/j.ejca.2019.12.029. Epub 2020 Jan 24.
Eur J Cancer. 2020.
PMID: 31986450
Free article.
Item in Clipboard
Cite
Cite